SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-001937
Filing Date
2019-02-15
Accepted
2019-02-15 08:35:39
Documents
2
Period of Report
2019-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1707
2 ex24beck.txt EX-24 4974
  Complete submission text file 0001179110-19-001937.txt   8127
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLD. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Beck Joanne T. (Reporting) CIK: 0001768045 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 19609925